These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2754616)
41. Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. Synthesis and antiulcer activity of the metabolites of 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid. Uchida M; Tabusa F; Komatsu M; Morita S; Kanbe T; Nakagawa K Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4821-4. PubMed ID: 3829195 [No Abstract] [Full Text] [Related]
42. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation. Petersen LC; Brender J; Suenson E Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638 [TBL] [Abstract][Full Text] [Related]
43. Absorption of tranexamic acid as a prodrug in healthy volunteers. Svahn CM; Schannong M; Stenberg U; Widlund L Arzneimittelforschung; 1988 May; 38(5):735-8. PubMed ID: 3415720 [TBL] [Abstract][Full Text] [Related]
44. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; synergistic drugs for protective factors in peptic ulcer]. Miyake T Nihon Rinsho; 1988 Jan; 46(1):79-83. PubMed ID: 3373760 [No Abstract] [Full Text] [Related]
45. Synthesis and antiulcer activity of optical isomers of 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid (rebamipide). Otsubo K; Morita S; Uchida M; Yamasaki K; Kanbe T; Shimizu T Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2906-9. PubMed ID: 1666022 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients. Kubota K; Shimizu N; Nozaki K; Takeshita Y; Ueda T; Imamura K; Hiki N; Yamaguchi H; Shimoyama S; MaFune K; Kaminishi M Dig Dis Sci; 2005 May; 50(5):842-6. PubMed ID: 15906755 [TBL] [Abstract][Full Text] [Related]
47. [Studies on antiulcer agents. III. Synthesis and antiulcer activity of phenylpropanol derivatives]. Muto Y; Ichikawa H; Seiki M; Shirataki Y; Yokoe I; Komatsu M Yakugaku Zasshi; 1995 Apr; 115(4):307-17. PubMed ID: 7602497 [TBL] [Abstract][Full Text] [Related]
48. DA-9601 for erosive gastritis: results of a double-blind placebo-controlled phase III clinical trial. Seol SY; Kim MH; Ryu JS; Choi MG; Shin DW; Ahn BO World J Gastroenterol; 2004 Aug; 10(16):2379-82. PubMed ID: 15285023 [TBL] [Abstract][Full Text] [Related]
49. [Synthesis of 3-aromatic ring substituted 2-(4-chlorobenzoylamino)propionic acid derivatives and their antiulcer activities]. Uchida M; Tabusa F; Komatsu M; Morita S; Kanbe T; Nakagawa K Yakugaku Zasshi; 1985 Nov; 105(11):1040-5. PubMed ID: 3835249 [No Abstract] [Full Text] [Related]
50. [Studies on antiulcer agents. IV. Synthesis and antiulcer activity of phenylpropanol derivatives]. Muto Y; Ichikawa H; Seiki M; Shirataki Y; Yokoe I; Komatsu M Yakugaku Zasshi; 1995 Apr; 115(4):318-28. PubMed ID: 7602498 [TBL] [Abstract][Full Text] [Related]
51. Crystal and molecular structures of a new anti-ulcer agent, 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride. Koyano K; Takeshita T; Takenaka A; Sasada Y Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3900-4. PubMed ID: 3815611 [No Abstract] [Full Text] [Related]
52. A novel class of antiulcer agents. 4-Phenyl-2-(1-piperazinyl)quinolines. Hino K; Kawashima K; Oka M; Nagai Y; Uno H; Matsumoto J Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):110-5. PubMed ID: 2720842 [TBL] [Abstract][Full Text] [Related]
53. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow. Hoshina K; Okada N; Inoue K; Yamamoto M; Saito N; Takeshita T; Naruchi T Arzneimittelforschung; 1987 Nov; 37(11):1284-9. PubMed ID: 3440037 [TBL] [Abstract][Full Text] [Related]
54. Metabolism of benzoate, cyclohex-1-ene carboxylate, and cyclohexane carboxylate by "Syntrophus aciditrophicus" strain SB in syntrophic association with H(2)-using microorganisms. Elshahed MS; Bhupathiraju VK; Wofford NQ; Nanny MA; McInerney MJ Appl Environ Microbiol; 2001 Apr; 67(4):1728-38. PubMed ID: 11282627 [TBL] [Abstract][Full Text] [Related]
55. A concise synthesis of a very late antigen-4 antagonist trans-4-[1-[[2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid via reductive etherification. Chiba J; Muro F; Setoguchi M; Machinaga N Chem Pharm Bull (Tokyo); 2012; 60(7):882-6. PubMed ID: 22790822 [TBL] [Abstract][Full Text] [Related]
56. Anti-ulcer effect of 1,6-dihydro-2-[2-(2-methylpropoxy) anilino]-6-oxo-5-pyrimidinecarboxylic acid on experimental gastric ulcers in rats. Ishizuka Y; Kamisaki T; Matsuda M; Shimazaki I; Kawashima M; Yaginuma H; Terashima K; Sato M Arzneimittelforschung; 1994 Apr; 44(4):509-13. PubMed ID: 8011005 [TBL] [Abstract][Full Text] [Related]
57. Syntheses of 2-(3,4-dimethoxyphenyl)ethylamine derivatives and their antiulcer activities. Hosokami T; Kuretani M; Higashi K; Asano M; Ohya K; Takasugi N; Mafune E; Miki T Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2712-9. PubMed ID: 1464101 [TBL] [Abstract][Full Text] [Related]